Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
Links shared publicly online about this topic.
- 896total visits
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Merck & Co., Merck KGaA
Most Recently Shared on September 5, 2010 at 4:00 pm By:
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia http://mnt.to/3JkB #regulatory
Also Shared By:
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia - Drugs.com MedNews
drugs.com — “Darmstadt, September 3, 2010 Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treat” View full resource at drugs.com
Most Recently Shared on September 4, 2010 at 11:41 am By:
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia: Darmstadt, September 3, 2010 – Merck KGaA... http://bit.ly/bhIY9L
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia - Drugs.com MedNews
drugs.com — “Darmstadt, September 3, 2010 Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treat” View full resource at drugs.com
Most Recently Shared on September 3, 2010 at 12:11 pm By:
Drugs and Devices OW OW Health
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia: Darmstadt, September 3, 2010 – Merck... http://bit.ly/aAu3a7 #drug
Pharmacy Europe - Merck KGaA hopes for drug approval
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on August 17, 2010 at 10:56 am By:
Merck KGaA hopes for drug approval: Merck KGaA has submitted its multiple sclerosis tablet Cladribine for US gover... http://bit.ly/bavXH7
Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting
news-medical.net — “EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company's multiple sclerosis portfolio of approved and investigational treatments will be presented at the 62nd Annual Meeting of the American Academy of Neurology taking place April 10 to 17, in Toronto, Canada.” View full resource at news-medical.net
Most Recently Shared on April 1, 2010 at 12:09 pm By:
Pregnancy News: Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting: EMD Serono... http://bit.ly/d8ysYj
FDA Rejects MS Drug Application - WSJ.com
online.wsj.com — “Merck KGaA on Monday said its application for U.S. approval of cladribine tablets for multiple sclerosis treatment has been rejected by the U.S. Food and Drug Administration.” View full resource at online.wsj.com
Most Recently Shared on December 2, 2009 at 9:01 pm By:
FDA Rejects MS Drug Application … http://short.to/yvp7
FDA Rejects MS Drug Application - WSJ.com
online.wsj.com — “Merck KGaA on Monday said its application for U.S. approval of cladribine tablets for multiple sclerosis treatment has been rejected by the U.S. Food and Drug Administration.” View full resource at online.wsj.com
Most Recently Shared on December 1, 2009 at 5:27 am By:
FDA Rejects Approval of MS Drug http://bit.ly/5vDBCQ
Advertisement
OrganizedWisdom MS
@MS_Wisdom2
Merck KGaA hopes for drug approval: Merck KGaA has submitted its multiple sclerosis tablet Cladribine for US gover... http://bit.ly/bavXH7
1 year ago...